Ruffer Portfolio holdings
Ruffer is an independent investment manager owned and run by its partners, with a single global strategy aimed at not losing money over any rolling 12-month period. Jonathan Ruffer, who began as a stockbroker and then became a barrister, started it in 1994 with Robert Shirley, 14th Earl Ferrers, and Jane Tufnell, and it became Ruffer LLP in 2004. The firm starts by weighing the risks it sees in markets and picking assets that should protect the portfolio if they come true, then takes on growth mainly through global stocks. It runs a stock-market-listed investment company, and its clients include pension plans, charities and family offices.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Synchrony
SYF
|
+$68.5M |
| 2 |
Cigna
CI
|
+$64.3M |
| 3 |
Newmont
NEM
|
+$42.6M |
| 4 |
eHealth
EHTH
|
+$41.5M |
| 5 |
Gold Fields
GFI
|
+$36.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$276M |
| 2 |
Walt Disney
DIS
|
+$99.1M |
| 3 |
Humana
HUM
|
+$92.1M |
| 4 |
Freeport-McMoran
FCX
|
+$89.6M |
| 5 |
ATVI
Activision Blizzard
ATVI
|
+$55.8M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 38.41% |
| 2 | Healthcare | 18.68% |
| 3 | Financials | 14.04% |
| 4 | Communication Services | 12.39% |
| 5 | Energy | 6.85% |
Similar funds
Ruffer's Q1 2020 Portfolio in Review
As of Q1 2020, Ruffer held 90 positions worth $2.2B, down 36% from $3.43B the previous quarter. Its ten largest holdings account for 66% of the portfolio.
Ruffer withdrew a net $359M in Q1 2020, closing 12 positions and reducing 30 holdings. Its most notable exit was McKesson, an estimated $15.7M position sold in full.
By sector, the portfolio is most concentrated in Materials at 38% of assets, up from 32% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Ruffer opened a new position in Nexstar Media Group worth $18.3M.
- Ruffer's largest Q1 2020 buy was Nexstar Media Group: 315,719 shares worth $18.3M.
- Ruffer added most to Synchrony in Q1 2020, an estimated $68.5M increase.
- Ruffer's biggest Q1 2020 reduction was Bristol-Myers Squibb, cutting an estimated $276M.
- Ruffer fully exited McKesson in Q1 2020, selling an estimated $15.7M.
- Ruffer's ten largest holdings make up 66% of its $2.2B portfolio in Q1 2020.
- Ruffer opened 9 new positions and closed 12 in Q1 2020.
- Ruffer's portfolio value fell 36% quarter-over-quarter to $2.2B.
Based on Ruffer's 13F filing for Q1 2020, filed 7 May 2020.